Glucagon Kit ELISA

N° du produit ABIN5526763

Détail du produit Glucagon Kit ELISA

Antigène: Glucagon (GCG)

Reactivité: Différentes espèces

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 8.42-5000 pg/mL

Seuil minimal de détection: 8.42 pg/mL

Application: ELISA

Fonction: This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of Glucagon.

Type d'échantillon: Plasma, Cell Culture Supernatant, Serum

Analytical Method: Quantitative

Specificité: Glucagon

Ingrédients: plate, standard, diluent

Matériel non inclus: pipettes, tubes, reader

Information d'application

Volume d'échantillon: 100 μL

Durée du test: 3 - 4 h

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Buffer: 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Détail du antigène

Antigène: Glucagon (GCG)

Autre désignation: Glucagon (GCG Produits)

Synonymes: GLP1 Kit ELISA, GLP2 Kit ELISA, GRPP Kit ELISA, GLP-1 Kit ELISA, Glu Kit ELISA, PPG Kit ELISA, GCG Kit ELISA, gcg-A Kit ELISA, gcg1 Kit ELISA, glucagon Kit ELISA, glucagon L homeolog Kit ELISA, GCG Kit ELISA, Gcg Kit ELISA, gcg.L Kit ELISA

Sujet: Glucagon is a 29-amino acid polypeptide, produced by alpha cells of the pancreas. The polypeptide has a molecular weight of 3485 Da that plays a critical role in glucose metabolism and homeostasis. It works to raise the concentration of glucose in the bloodstream. It is also used as a medication to treat a number of health conditions. Its effect is opposite to that of insulin, which lowers the glucose. The pancreas releases glucagon when the concentration of glucose in the bloodstream falls too low. Glucagon causes the liver to convert stored glycogen into glucose, which is released into the bloodstream. High blood-glucose levels, on the other hand, stimulate the release of insulin. Glucagon allows glucose to be taken up and used by insulin-dependent tissues. Thus, glucagon and insulin are part of a feedback system that keeps blood glucose levels stable. Abnormally elevated levels of glucagon may be caused by pancreatic tumors, such as glucagonoma, symptoms of which include necrolytic migratory erythema, reduced amino acids, and hyperglycemia. It may occur alone or in the context of multiple endocrine neoplasia type 1.

NCBI Accession: NM_002054

UniProt: P01275

Pathways: Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, cAMP Metabolic Process, Regulation of Carbohydrate Metabolic Process, Feeding Behaviour, Negative Regulation of intrinsic apoptotic Signaling